HIPK1 inhibition prevents pathological cardiac hypertrophy through inhibiting the cAMP response element binding protein (CREB) phosphorylation at Ser271 and inactivating CCAAT/enhancer‐binding protein β (C/EBPβ). Here, HIPK1 is linked to cardiac hypertrophy.